Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The mitochondriotoxic domain of Vpr determines HIV-1 virulence
Catherine Brenner, Guido Kroemer
Catherine Brenner, Guido Kroemer
View: Text | PDF
Commentary

The mitochondriotoxic domain of Vpr determines HIV-1 virulence

  • Text
  • PDF
Abstract

Authors

Catherine Brenner, Guido Kroemer

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Impact of the R77Q mutation of Vpr on the conformation of Vpr and the in...
Impact of the R77Q mutation of Vpr on the conformation of Vpr and the interaction between Vpr and ANT. (a) Representation of wild-type (R77) Vpr and R77Q Vpr. Three amphipathic helices (shown in red and yellow) are linked by turns (green) and flexible loops (gray). The mitochondriotoxic domain of Vpr has been marked in yellow. Only the side chain of amino acid 77 is shown. (b) View of the arginine residues (R73, R77, R80) within the mitochondriotoxic domain of Vpr (yellow) and the aromatic residues of ANT (F109, W111, Y113 and/or F114) involved in cation-π interactions, as calculated by molecular modeling (10). The inner mitochondrial membrane (dark blue) is indicated to facilitate the topological orientation of the third loop (residues 104–116) of ANT. C, carboxy terminus; N, amino terminus; L134 and R72 are amino residues of ANT.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts